Monday, 28 October 2013

Alexion obtains FDA breakthrough therapy status for cPMP to treat MoCD type A disorder « New Drug Approvals

Alexion obtains FDA breakthrough therapy status for cPMP to treat MoCD type A disorder « New Drug Approvals:

'via Blog this'

No comments:

Post a Comment